Arcoma AB

OM:ARCOMA 株式レポート

時価総額:SEK 196.5m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Arcoma 過去の業績

過去 基準チェック /46

Arcomaの収益は年間平均-22.2%の割合で減少していますが、 Medical Equipment業界の収益は年間 増加しています。収益は年間17% 3.2%割合で 増加しています。 Arcomaの自己資本利益率は17.8%であり、純利益率は5.5%です。

主要情報

-8.5%

収益成長率

-9.5%

EPS成長率

Medical Equipment 業界の成長6.2%
収益成長率4.9%
株主資本利益率22.4%
ネット・マージン7.2%
次回の業績アップデート24 Oct 2024

最近の業績更新

Solid Earnings Reflect Arcoma's (STO:ARCOMA) Strength As A Business

Aug 22
Solid Earnings Reflect Arcoma's (STO:ARCOMA) Strength As A Business

Recent updates

Solid Earnings Reflect Arcoma's (STO:ARCOMA) Strength As A Business

Aug 22
Solid Earnings Reflect Arcoma's (STO:ARCOMA) Strength As A Business

At kr15.20, Is Arcoma AB (STO:ARCOMA) Worth Looking At Closely?

Aug 07
At kr15.20, Is Arcoma AB (STO:ARCOMA) Worth Looking At Closely?

Is Now The Time To Look At Buying Arcoma AB (STO:ARCOMA)?

Apr 26
Is Now The Time To Look At Buying Arcoma AB (STO:ARCOMA)?

Arcoma AB's (STO:ARCOMA) P/E Is Still On The Mark Following 25% Share Price Bounce

Feb 06
Arcoma AB's (STO:ARCOMA) P/E Is Still On The Mark Following 25% Share Price Bounce

Is Arcoma (STO:ARCOMA) A Risky Investment?

Jan 15
Is Arcoma (STO:ARCOMA) A Risky Investment?

We Think Arcoma (STO:ARCOMA) Is Taking Some Risk With Its Debt

Sep 11
We Think Arcoma (STO:ARCOMA) Is Taking Some Risk With Its Debt

Is Arcoma (STO:ARCOMA) Using Too Much Debt?

Jun 08
Is Arcoma (STO:ARCOMA) Using Too Much Debt?

Is Arcoma AB (STO:ARCOMA) Potentially Undervalued?

Apr 27
Is Arcoma AB (STO:ARCOMA) Potentially Undervalued?

Does Arcoma (STO:ARCOMA) Have A Healthy Balance Sheet?

Dec 22
Does Arcoma (STO:ARCOMA) Have A Healthy Balance Sheet?

Is Arcoma (STO:ARCOMA) Using Too Much Debt?

May 03
Is Arcoma (STO:ARCOMA) Using Too Much Debt?

These 4 Measures Indicate That Arcoma (STO:ARCOMA) Is Using Debt Extensively

Oct 28
These 4 Measures Indicate That Arcoma (STO:ARCOMA) Is Using Debt Extensively

Is Arcoma (STO:ARCOMA) A Risky Investment?

Mar 17
Is Arcoma (STO:ARCOMA) A Risky Investment?

Is Arcoma AB (STO:ARCOMA) Potentially Undervalued?

Feb 04
Is Arcoma AB (STO:ARCOMA) Potentially Undervalued?

Have Insiders Sold Arcoma AB (STO:ARCOMA) Shares Recently?

Jan 14
Have Insiders Sold Arcoma AB (STO:ARCOMA) Shares Recently?

Arcoma AB's (STO:ARCOMA) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Jan 12
Arcoma AB's (STO:ARCOMA) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

These 4 Measures Indicate That Arcoma (STO:ARCOMA) Is Using Debt Reasonably Well

Dec 17
These 4 Measures Indicate That Arcoma (STO:ARCOMA) Is Using Debt Reasonably Well

Estimating The Fair Value Of Arcoma AB (STO:ARCOMA)

Nov 21
Estimating The Fair Value Of Arcoma AB (STO:ARCOMA)

収支内訳

Arcoma の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

OM:ARCOMA 収益、費用、利益 ( )SEK Millions
日付収益収益G+A経費研究開発費
30 Jun 2417513450
31 Mar 241729450
31 Dec 231633450
30 Sep 231530460
30 Jun 231460450
31 Mar 231381440
31 Dec 221252430
30 Sep 22105-6440
30 Jun 2299-10440
31 Mar 22105-11440
31 Dec 21117-7450
30 Sep 21126-6450
30 Jun 21125-2440
31 Mar 21121-1410
31 Dec 201171380
30 Sep 201228340
30 Jun 2013010360
31 Mar 2013210380
31 Dec 191347390
30 Sep 191335400
30 Jun 191322400
31 Mar 191291410
31 Dec 18119-2420
30 Sep 18111-1420
30 Jun 1898-6420
31 Mar 1894-10410
31 Dec 1792-10400
30 Sep 1798-9410
30 Jun 17108-4420
31 Mar 17106-5450
31 Dec 16102-12470
30 Sep 16106-12490
30 Jun 16105-13480
31 Mar 16104-15480
31 Dec 15123-6490
30 Sep 15117-6470
30 Jun 15119-5460
31 Mar 151331470
31 Dec 141301450
30 Sep 14134-7480
31 Dec 13108-14500

質の高い収益: ARCOMAは 高品質の収益 を持っています。

利益率の向上: ARCOMA過去に利益を上げました。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: ARCOMA過去 5 年間で収益を上げており、収益は年間-22.2%増加しています。

成長の加速: ARCOMAは昨年収益を上げたため、収益成長率を 5 年間の平均と比較することは困難です。

収益対業界: ARCOMA昨年収益を上げたため、昨年の収益成長をMedical Equipment業界 ( 44.1% ) と比較することは困難です。


株主資本利益率

高いROE: ARCOMAの 自己資本利益率 ( 22.4% ) は 高い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘